Capromab pendetide-indium 111 is a radiolabeled murine monoclonal IgG1k directed against prostate specific membrane antigen (PSMA) for use as a diagnostic imaging modality. PSMA is a cytoplasmic glycoprotein found in local and metastatic adenocarcinoma of the prostate. Capromab pendetide is indicated as an adjunctive imaging tool in newly diagnosed patients suspected to be high-risk for metastatic prostate cancer.
Diagnostic imaging of metastatic prostate cancer in newly diagnosed, high-risk patients
| Source | Link | Revision Date | Access Date |
| ProstaScint | http://www.prostascintimaging.com/ | 1997-August-07 | 2008-May-30 |
NO RELIANCE FOR MEDICAL DECISIONSInformation, services and/or other features contained in this web site (including any electronic bulletin board contained therein) are being provided for general educational and informational purposes only and are not intended to be a substitute for independent medical judgment or constitute case-specific medical advice or treatment in any way. Such information, services and/or features are not intended to serve as the primary basis for making personal or professional medical decisions, nor are they intended to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to making any treatment or diagnosis decisions and with any questions you may have regarding a medical condition or its diagnosis or treatment. You should confirm any information obtained from this site with other sources before undertaking any treatment or otherwise taking any actions relating thereto. Any reliance on any information, services or other features contained in this site is solely at your own risk. |
|
Clinical Immunology Society 555 East Wells Street, Suite 1100 Milwaukee, WI 53202-3823 USA Phone: 414/224-8095 | Fax: 414/272-6070 Email: info@clinimmsoc.org © 2001-2011 Clinical Immunology Society | Web Site Disclaimer |
